– UK, High Wycombe – Ashley House plc (AIM:ASH), the health and community care property partner is pleased to announce the following new appointment to the Board.
James Andrew John Hathaway has been appointed Finance Director & Company Secretary with effect from today. James is a Chartered Accountant and has been with Ashley House since 2011 as Director of Finance and member of the Senior Management Team having previously worked for Tenon and Fujitsu Services. He joins Antony Walters and Jonathan Holmes as an Executive Director of the Company.
James also takes the position of Company Secretary in place of Stephen Ronaldson who retires from this position after more than 10 years’ service.
Further to the above, Andrew Willetts, Non-executive director and Chairman of the Company’s Audit & Risk Committee, was appointed to the Board in 2009 following the acquisition of Sapphire Primary Care Developments from Admenta Ltd (Lloyds Pharmacy). Andrew recently left Admenta but has agreed to remain on the Board of Ashley House plc as a Non-executive director and Chairman of the Company’s Audit & Risk Committee until at least the publication of the financial statements for the year to 30 April 2018.
Christopher Lyons, Chairman of Ashley House commented “We are delighted to announce James’ appointment. James brings experience as well as financial and strategic expertise to the Board. This is an important appointment for the Company as we ensure that the Board’s composition and structure is appropriate to enable the Company to grow over the coming years. We thank Stephen Ronaldson for his long service as Company Secretary since 2007. I am also pleased that Andrew has agreed to remain on the Board and will continue to provide his invaluable support and advice.”
For more information : http://www.ashleyhouseplc.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
